Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder

Schizophrenia Research

Volumn 129, Issue 2-3, 2011, Pages 183-190

  Abdolmaleky, Hamid Mostafavi ^a,d   Yaqubi, Sahab ^a,b   Papageorgis, Panagiotis ^a   Lambert, Arthur W ^a   Ozturk, Sait ^a   Sivaraman, Vadivelu ^c   Thiagalingam, Sam ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bipolar disorder; Brain; DNA methylation; HTR2A; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CYTOSINE; DNA; NEUROLEPTIC AGENT; SEROTONIN 2 RECEPTOR; VALPROIC ACID;

ALLELE; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; CPG ISLAND; DNA FLANKING REGION; DNA METHYLATION; DNA POLYMORPHISM; DNA SEQUENCE; DOWN REGULATION; DRUG USE; EPIGENETICS; EXON; GENDER; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; ONSET AGE; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

BIPOLAR DISORDER; CELL ADHESION MOLECULES, NEURONAL; CHI-SQUARE DISTRIBUTION; CYTOSINE; DNA METHYLATION; EXTRACELLULAR MATRIX PROTEINS; FRONTAL LOBE; GENE FREQUENCY; GENOTYPE; GUANINE; HUMANS; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE; SCHIZOPHRENIA; SERINE ENDOPEPTIDASES; STATISTICS AS TOPIC;

EID: 79958009147     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.04.007     Document Type: Article

References (44)

1. Abdolmaleky H.M., Faraone S.V., Glatt S.J., Tsuang M.T. Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia. Schizophr. Res. 2004, 67(1):53-62.
2. Abdolmaleky H.M., Smith C.L., Faraone S.V., Shafa R., Stone W., Glatt S.J., Tsuang M.T. Methylomics in psychiatry: modulation of gene-environment interactions may be through DNA methylation. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004, 127B(1):51-59.
3. Abdolmaleky H.M., Cheng K.H., Russo A., Smith C.L., Faraone S.V., Wilcox M., Shafa R., Glatt S.J., Nguyen G., Ponte J.F., Thiagalingam S., Tsuang M.T. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 134(1):60-66.
4. Abdolmaleky H.M., Cheng K.H., Faraone S.V., Wilcox M., Glatt S.J., Gao F., Smith C.L., Shafa R., Aeali B., Carnevale J., Pan H., Papageorgis P., Ponte J.F., Sivaraman V., Tsuang M.T., Thiagalingam S. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. 2006, 15(21):3132-3145.
5. Abdolmaleky H.M., Smith C.L., Zhou J.-R., Thiagalingam S. Epigenetic alterations of the dopaminergic system in major psychiatric disorders. Pharmacogenomics in drug discovery and development. Methods in Molecular Biology 2008, 187-212. Humana Press Inc., Totowa, NJ. J. Walker, Q. Yan (Eds.).
6. Abdolmaleky H.M., Smith C.L., Zhou J.-R., Thiagalingam S. Epigenetic modulation of reelin function in schizophrenia and bipolar disorder. Reelin Glycoprotein, Biology, Structure and Roles in Health and Disease 2008, 365-384. Springer, New York. S.H. Fatemi (Ed.).
7. Akbarian S. The molecular pathology of schizophrenia-focus on histone and DNA modifications. Brain Res. Bull. 2010, 83(3-4):103-107.
8. Alexander D.M., Flynn G.J., Wong W., Whitford T.J., Harris A.W., Galletly C.A., Silverstein S.M. Clin. Neurophysiol. 2009, 120(9):1667-1682.
9. Arranz M., Collier D., Sodhi M., Ball D., Roberts G., Price J., Sham P., Kerwin R. Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 1995, 346(8970):281-282.
10. Bethea C.L., Reddy A.P., Tokuyama Y., Henderson J.A., Lima F.B. Protective actions of ovarian hormones in the serotonin system of macaques. Front. Neuroendocrinol. 2009, 30(2):212-238. (Review).
11. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16(1):6-21.
12. Bortolozzi A., Diaz-Mataix L., Scorza M.C., Celada P., Artigas F. The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. J. Neurochem. 2005, 95(6):1597-1607.
13. Bray N.J., Buckland P.R., Hall H., Owen M.J., O'Donovan M.C. The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain. Mol. Psychiatry 2004, 9(1):109-114.
14. Broman S.H., Fletcher J.M. The Changing Nervous System: Neurobehavioral Consequences of Early Brain Disorders 1999, 3-93. New York.
15. Bunzel R., Blumcke S., Cichon S., Normann J., Schramm P., Propping P., Nothen M.M. Polymorphic imprinting of the serotonin-2A (5-HT2A) receptor gene in human adult brain. Brain Res. Mol. Brain Res. 1998, 59:90-92.
16. De Luca V., Viggiano E., Dhoot R., Kennedy J.L., Wong A.H. Methylation and QTDT analysis of the 5-HT2A receptor 102 C allele: analysis of suicidality in major psychosis. J. Psychiatr. Res. 2009, 43(5):532-537.
17. Enoch M.A., Kaye W.H., Rotondo A., Greenberg B.D., Murphy D.L., Goldman D. 5HT2A promoter polymorphism -1438G/A, anorexia nervosa, and obsessive-compulsive disorder. Lancet 1998, 351(9118):1785-1786.
18. Frommer M., McDonald L.E., Millar D.S., Collis C.M., Watt F., Grigg G.W., Molloy P.L., Paul C.L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:1827-1831.
19. Garbett K., Gal-Chis R., Gaszner G., Lewis D.A., Mirnics K. Transcriptome alterations in the prefrontal cortex of subjects with schizophrenia who committed suicide. Neuropsychopharmacol. Hung. 2008, 10(1):9-14.
20. Ghadirivasfi, M., Nohesara. S., Ahmadkhaniha, H.R., Eskandari, M.R., Thiagalingam, S., Abdolmaleky, H.M., in press. Hypomethylation of the serotonin receptor type-2A gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.
21. Grayson D.R., Jia X., Chen Y., Sharma R.P., Mitchell C.P., Guidotti A., Costa E. Reelin promoter hypermethylation in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(26):9341-9346.
22. Hernandez I., Sokolov B.P. Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment. J. Neurosci. Res. 2000, 59(2):218-225.
23. Huang H.S., Akbarian S. GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia. PLoS One 2006, 2(8):e809.
24. Hurlemann R., Matusch A., Kuhn K.U., Berning J., Elmenhorst D., Winz O., Kolsch H., Zilles K., Wagner M., Maier W., Bauer A. 5-HT2A receptor density is decreased in the at-risk mental state. Psychopharmacology (Berl.) 2008, 195(4):579-590.
25. Irizarry R.A., Ladd-Acosta C., Wen B., Wu Z., Montano C., Onyango P., Cui H., Gabo K., Rongione M., Webster M., Ji H., Potash J.B., Sabunciyan S., Feinberg A.P. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 2009, 41(2):178-186.
26. Kandel E.R. The molecular biology of memory storage: a dialogue between genes and synapses. Science 2001, 294(5544):1030-1038.
27. Kato M.V., Shimizu T., Nagayoshi M., Kaneko A., Sasaki M.S., Ikawa Y. Genomic imprinting of the human serotonin-receptor (HTR2) gene involved in development of retinoblastoma. Am. J. Hum. Genet. 1996, 59(5):1084-1090.
28. Khait V.D., Huang Y.Y., Zalsman G., Oquendo M.A., Brent D.A., Harkavy-Friedman J.M., Mann J.J. Association of serotonin 5-HT2A receptor binding and the T102C polymorphism in depressed and healthy Caucasian subjects. Neuropsychopharmacology 2005, 30(1):166-172.
29. Knyazeva M.G., Jalili M., Meuli R., Hasler M., De Feo O., Do K.Q. Acta Psychiatr. Scand. 2008, 118(3):188-199.
30. Meda S.A., Giuliani N.R., Calhoun V.D., Jagannathan K., Schretlen D.J., Pulver A., Cascella N., Keshavan M., Kates W., Buchanan R., Sharma T., Pearlson G.D. A large scale (N=400) investigation of gray matter differences in schizophrenia using optimized voxel-based morphometry. Schizophr. Res. 2008, 101(1-3):95-105.
31. Minzenberg M.J., Laird A.R., Thelen S., Carter C.S., Glahn D.C. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch. Gen. Psychiatry 2009, 66(8):811-822.
32. Morita K., Her S. Progesterone pretreatment enhances serotonin-stimulated BDNF gene expression in rat c6 glioma cells through production of 5alpha-reduced neurosteroids. J. Mol. Neurosci. 2008, 34(3):193-200.
33. Parsons M.J., D'Souza U.M., Arranz M.J., Kerwin R.W., Makoff A.J. The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biol. Psychiatry 2004, 56(6):406-410.
34. Petronis A. The genes for major psychosis: aberrant sequence or regulation?. Neuropsychopharmacology 2000, 23:1-12.
35. Petronis A., Gottesman I.I., Kan P., Kennedy J.L., Basile V.S., Paterson A.D., Popendikyte V. Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance?. Schizophr. Bull. 2003, 29(1):169-178.
36. Polesskaya O.O., Sokolov B.P. Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J. Neurosci. Res. 2002, 67(6):812-822.
37. Polesskaya O.O., Aston C., Sokolov B.P. Allele C-specific methylation of the 5-HT2A receptor gene: evidence for correlation with its expression and expression of DNA methylase DNMT1. J. Neurosci. Res. 2006, 83(3):362-373.
38. Saddock B., Saddock V. Kaplan and Sadock's Comprehensive Textbook of Psychiatry 2008, Vol 1. Lippincott Williams & Wilkins, Philadelphia, PA. 9 ed.
39. Singal R., Ginder G.D. DNA methylation. Blood 1999, 93(12):4059-4070.
40. Sodhi M.S., Sanders-Bush E. Serotonin and brain development. Int. Rev. Neurobiol. 2004, 59:111-174.
41. Tsuchiya S., Tanaka S., Sugimoto Y., Katsuyama M., Ikegami R., Ichikawa A. Identification and characterization of a novel progesterone receptor-binding element in the mouse prostaglandin E receptor subtype EP2 gene. Genes Cells 2003, 8(9):747-758.
42. Turecki G., Briere R., Dewar K., Antonetti T., Lesage A.D., Seguin M., Chawky N., Vanier C., Alda M., Joober R., Benkelfat C., Rouleau G.A. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am. J. Psychiatry 1999, 156(9):1456-1458.
43. Walitza S., Wewetzer C., Warnke A., Gerlach M., Geller F., Gerber G., Gorg T., Herpetz-Dahlmann B., Schulz E., Remschmidt H., Hebebrand J., Hinney A. 5-HT(2A) promoter polymorphism -1438G/A in children and adolescents with obsessive-compulsive disorders. Mol. Psychiatry 2002, 7(10):1054-1057.
44. Williams J., McGuffin P., Nothen M., Owen M.J. Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia. Lancet 1997, 349(9060):1221.